Dyne Therapeutics Inc (DYN) — Cash Flow Reinvestment Rate
Dyne Therapeutics Inc (DYN) has a Cash Flow Reinvestment Rate of 2.73x as of December 2017, reinvesting $229.00 Million (capex $224.00 Million plus investments $5.00 Million) from operating cash flow of $84.00 Million. Check DYN cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Dyne Therapeutics Inc Cash Flow Reinvestment Rate (2007–2017)
Historical reinvestment intensity for Dyne Therapeutics Inc across 8 annual periods. Explore long-term investment intensity of Dyne Therapeutics Inc to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Dyne Therapeutics Inc (2007–2017)
Year-by-year capital reinvestment analysis for Dyne Therapeutics Inc. For live market cap and broader valuation context, see market cap of Dyne Therapeutics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2017 | 0.38x | $224.00 Million | $585.00 Million | $224.00 Million | ▼ -20.6% |
| 2016 | 0.48x | $326.00 Million | $676.00 Million | $326.00 Million | ▼ -83.5% |
| 2015 | 2.93x | $275.00 Million | $94.00 Million | $275.00 Million | ▲ +422.4% |
| 2013 | 0.56x | $98.00 Million | $175.00 Million | $98.00 Million | ▼ -28.9% |
| 2010 | 0.79x | $333.00 Million | $423.00 Million | $333.00 Million | — |
| 2009 | 0.00x | $0.00 | $135.00 Million | $0.00 | — |
| 2008 | 0.00x | $0.00 | $319.00 Million | $0.00 | — |
| 2007 | 0.00x | $0.00 | $341.00 Million | $0.00 | — |